Going for the ‘Trifecta’ With This Biopharma Trade
Here’s a covered call strategy for an appealing pharma name.
Old-Timers Called It Glass Works. What Call Should Today’s Traders Make?
A very good quarter and guidance, but bearish signaling has me calling it this way.
This Mid-Cap Biotech’s Pullback Just Created a Trade I Can’t Ignore
The stock has fallen about 15% from its October highs. My strategy offers both double-digit upside potential and downside protection.
Three Biotechs Bolstered by Positive News
Biotech has been a market laggard lately, but I’m eyeing three companies making recent progress.
2 Names I’m Adding to as Expirations Create Dry Powder
Here are the top two positions worthy of additions as my cash position grows.
A Covered Call Strategy to Avoid Greed in a Stretched Market
Value investors should consider this strategy as sound stocks become harder to find.
Looking for Cash Flow, Not AI Hype? Here’s the Trade for You.
The older I get, the more I like this stock.
An Attractive Bet on an Ugly Duckling
Here is how I took a small stake in a name with ‘a lot of warts.’
Our Option Strategy for a Grocery Chain on The Right Side of the K-Shaped Economy
This strategy delivers downside protection of 20% across the trade expiration.